MRK - Merck & Co., Inc.

NYSE - NYSE Delayed price. Currency in USD

Cash flow

Annual
All numbers in thousands
Period ending31/12/201831/12/201731/12/201631/12/2015
Net income6,220,0002,394,0003,920,0004,442,000
Operating activities, cash flow provided by or used in
Depreciation4,520,0004,616,0005,244,0006,201,000
Adjustments to net income1,735,0004,458,0003,813,0002,163,000
Changes in accounts receivable-418,000297,000-619,000-480,000
Changes in liabilities230,000254,000278,000-37,000
Changes in inventory-911,000-145,000206,000805,000
Changes in other operating activities-1,281,000-2,132,000-2,590,000-290,000
Total cash flow from operating activities10,922,0006,451,00010,376,00012,538,000
Investment activities, cash flow provided by or used in
Capital expenditure-2,615,000-1,888,000-1,614,000-1,283,000
Investments7,258,0004,925,000-1,298,0003,732,000
Other cash flow from investment activities102,00038,000482,000221,000
Total cash flow from investment activities4,314,0002,679,000-3,210,000-4,758,000
Financing activities, cash flow provided by or used in
Dividends paid-5,172,000-5,167,000-5,124,000-5,117,000
Sale purchase of stock----
Net borrowings837,000-1,129,000-1,307,0003,492,000
Other cash flow from financing activities-325,000-195,000-118,000-61,000
Total cash flow from financing activities-13,160,000-10,006,000-9,044,000-5,387,000
Effect of exchange rate changes-205,000457,000-131,000-1,310,000
Change in cash and cash equivalents1,871,000-419,000-2,009,0001,083,000
By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes